Mujtaba, S., Zeng, L., and Zhou, M. Structure and acetyl-lysine recognition of the bromodomain. Oncogene 26 5521-5527 (2011).

Florence, B., and Faller, D.V. You bet-cha: A novel family of transcriptional regulators. Front Biosci 6 D1008-D1018 (2011).

Liu, Y., Wang, X., Zhang, J., et al. Structural basics and binding properties of the second bromodomain of Brd4 with acetylated histone tails. Biochem 47 6403-6417 (2008).

Day, A., Chitsaz, F., Abbasi, A., et al. The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis. Proc Natl Acad Sci USA 100(15) 8758-8763 (2003).

Umehara, T., Nakamura, Y., Jang, M.K., et al. Structural basis for acetylated histone H4 recognition by the human BRD2 bromodomain. J Biol Chem 2855(10) 7610-7618 (2010).

Zhang, J., Chung, T.D.Y., and Oldenburg, K.R. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 4(2) 67-73 (1999).

Filippakopoulos, P., Qi, J., Picaud, S., et al. Selective inhibition of BET bromodomains. Nature 468(7327) 1067-1073 (2010).

Hewings, D.S., Wang, M., Philpott, M., et al. 3,5-Dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands. J Med Chem 1-30 (2011).

Chung, C.W., Coste, H., White, J.H., et al. Discovery and characterization of small molecule inhibitors of the BET family bromodomains. J Med Chem 54(11) 3827-3838 (2011).

Delmore, J.E., Issa, G.C., Lemieux, M.E., et al. BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 146(6) 904-917 (2011).

Hargreaves, D.C., Horng, T., and Medzhitov, R. Control of inducible gene expression by signal-dependent transcriptional elongation. Cell 138(1) 129-45 (2009).

Dawson, M.A., Prinjha, R.K., Dittmann, A., et al. Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia. Nature 478 529-533 (2011).

Nicodeme, E., Jeffrey, K.L., Schaefer, U., et al. Suppression of inflammation by a synthetic histone mimic. Nature 468(7327) 1119-23 (2010).

Philpott, M., Yang, J., Tumber, T., et al. Bromodomain-peptide displacement assays for interactome mapping and inhibitor discovery. Mol BioSyst 7(10) 2899-2908 (2011).

Mertz, J.A., Conery, A.R., Bryant, B.M., et al. Targeting MYC dependence in cancer by inhibiting BET bromodomains. Proc Natl Acad Sci USA 108(40) 16669-16674 (2011).

LeRoy, G., Rickards, B., and Flint, S.J. The double bromodomain proteins Brd2 and Brd3 couple histone acetylation to transcription. Mol Cell 30(1) 51-60 (2008).

Weidner-Glunde, M., Ottinger, M., and Schulz, T.F. WHAT do viruses BET on? Front Biosci 15 537-549 (2010).

Umehara, T., Nakamura, Y., Wakamori, M., et al. Structural implications for K5/K12-di-acetylated histone H4 recognition by the second bromodomain of BRD2. FEBS Lett 584(18) 3901-3908 (2010).